Clinical trial
G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing…
NCT00397423 · Peking University, Other · Completed
Key facts
| NCT number | NCT00397423 |
|---|---|
| Title | G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response |
| Official title | Granulocyte-Colony Stimulating Factor Treatment for Amyotrophic Lateral Sclerosis: A Randomized Control Trial Study Assessing Clinical Response |
| Lead sponsor | Peking University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis |
| Intervention type | Drug |
| Interventions | Granulocyte Colony Stimulating Factor, NS |
| Enrollment | 40 |
| Start date | Dec 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Nov 9, 2006 |
| Last update posted | Nov 28, 2007 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: